Epidemiology of colorectal cancer

International Journal of Molecular Epidemiology and Genetics

Volumn 7, Issue 3, 2016, Pages 105-114

  Marley, Andrew R ^a   Nan, Hongmei ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Epidemiology; Prevention and control; Review; Risk factors; Screening; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; VITAMIN D;

COLORECTAL CANCER; ENVIRONMENTAL FACTOR; GENE INTERACTION; HEREDITY; HUMAN; PUBLIC HEALTH; REVIEW; RISK FACTOR; SCREENING; TIME;

EID: 84991712902     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. What is colorectal cancer? [Internet]. Cancer.org; 2016 [17 May 2016]. Available from: http://www.cancer.org/cancer/colonandrectumca-ncer/detailedguide/colorectal-cancer-what-is-colorectal-cancer.
2. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-92.
3. Colorectal Cancer: Overview [Internet]. Cancer.net; 2015 [19 October 2015]. Available from: http://www.cancer.net/cancer-types/colorectal-cancer/overview.
4. Cancer Facts & Figures 2016 [Internet]. Cancer.org; 2016 [17 May 2016]. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-04-7079.pdf.
5. Cancer of the Colon and Rectum-SEER Stat Fact Sheets [Internet]. Seer.cancer.gov; [17 May 2016]. Available from: http://seer.cancer.gov/statfacts/html/colorect.html.
6. Browse the SEER Cancer Statistics Review 1975-2013. [Internet]. Seer.cancer.gov; [17 May 2016]. Available from: http://seer.cancer.gov/csr/1975_2013/browse_csr.php?sectionSEL=6&pageSEL=sect_06_table.09.html.
7. Browse the SEER Cancer Statistics Review 19-75-2013 [Internet]. Seer.cancer.gov; [17 May 2016]. Available from: http://seer.cancer.gov/csr/1975_2013/browse_csr.php?sectionSEL=6&pageSEL=sect_06_table.06.html.
8. Cancer of the Colon and Rectum (Invasive) 5-Year Relative and Period Survival by Race, Sex, Diagnosis Year, Age and Stage at Diagnosis [Internet]. Seer.cancer.gov; [17 May 2016]. Available from: http://seer.cancer.gov/csr/19-75_2013/browse_csr.php?sectionSEL=6&pageSEL=sect_06_table.12.html.
9. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
10. Khuhaprema T, Srivatanakul P. Colon and rectum cancer in Thailand: an overview. Jpn J Clin Oncol 2008; 38: 237-43.
11. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: molecular epidemiology and screening strategies. J Cancer Epidemiol 2015; 2015: 643020.
12. Ibrahim EM, Zeeneldin AA, El-Khodary TR, Al-Gahmi AM, Bin Sadiq BM. Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol 2008; 14: 178.
13. Kaw LL, Punzalan CK, Crisostomo AC, Bowyer MW, Wherry DC. Surgical pathology of colorectal cancer in Filipinos: implications for clinical practice. J Am Coll Surg 2002; 195: 188-95.
14. Al-Jaberi TM, Ammari F, Gharieybeh K, Khammash M, Yaghan RJ, Heis H, Al-Omari M, Al-Omari N. Colorectal adenocarcinoma in a defined Jordanian population from 1990 to 1995. Dis Colon Rectum 1997; 40: 1089-94.
15. Sung JJ, Lau JY, Goh KL, Leung WK; Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871-6.
16. Stigliano V, Sanchez-Mete L, Martayan A, Anti M. Early-onset colorectal cancer: A sporadic or inherited. World J Gastroenterol 2014; 20: 12420-30.
17. Keswani SG, Boyle MJ, Maxwell JP 4th, Mains L. Colorectal cancer in patients younger than 40 years of age. Am Surg 2002; 68: 871.
18. Abou-Zeid AA, Khafagy W, Marzouk DM, Alaa A, Mostafa I, Ela MA. Colorectal cancer in Egypt. Dis Colon Rectum 2002; 45: 1255-60.
19. Mansoor I, Zahrani IH, Aziz SA. Colorectal cancers in Saudi Arabia. Saudi Med J 2002; 23: 322-7.
20. Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol 2014; 20: 6055-72.
21. Wynder E, Kajitani T, Ishikawa S, Dodo H, Takano A. Environmental factors of cancer of the colon and rectum II. Japanese epidemiological data. Cancer 1969; 23: 1210-20.
22. Harris R. Global epidemiology of cancer. Burlington, MA: Jones Bartlett; 2016.
23. Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C. Alcohol consumption and cancer risk. Nutr Cancer 2011; 63: 983-90.
24. Homann N, Tillonen J, Salaspuro M. Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency. Int J Cancer 2000; 86: 169-73.
25. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999; 55: 578-92.
26. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 2765-78.
27. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 725-31.
28. Lopez-Morra HA, Linn S, Tejada J, Ofori EA, Guzman LG, Sanivarapu S, et al. Sa1444 Does Insulin Influence the Risk of Colon Adenomas and Colorectal Cancer? a Multicenter Look At a Minority Population. Gastrointestinal Endoscopy 2014; 79: AB214.
29. Yashiro M. Ulcerative colitis-associated colo-rectal cancer. World J Gastroenterol 2014; 20: 16389-97.
30. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr 2004; 7: 187-200.
31. Wu K, Giovannucci E, Byrne C, Platz EA, Fuchs C, Willett WC, Sinha R. Meat mutagens and risk of distal colon adenoma in a cohort of US men. Cancer Epidemiol Biomarkers Prev 2006; 15: 1120-5.
32. Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Annu Rev Nutr 1999; 19: 545-86.
33. Caygill C, Hill M. Fish, n-3 fatty acids and human colorectal and breast cancer mortality. Eur J Cancer Prev 1995; 4: 329-32.
34. Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer 1971; 28: 3-13.
35. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005; 97: 179-94.
36. Schmid D, Leitzmann M. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 2014; 25: 1293-311.
37. Baena R, Salinas P. Diet and colorectal cancer. Maturitas 2015; 80: 258-64.
38. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356: 2131-42.
39. Querido J. Twenty-five years since landmark bowel cancer discovery [Internet]. Cancer Research UK-Science blog; 2012 [19 October 2015]. Available from: http://scienceblog.cancerresearchuk.org/2012/08/28/twenty-five-years-since-landmark-bowel-cancer-discovery/.
40. Bert Vogelstein, MD [Internet]. ASCO; 2009 [13 June 2016]. Available from: https://www.asco.org/people/bert-vogelstein,-md.
41. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, Phillips A, Wesley E, Parnell K, Zhang H, Drummond H, Nimmo ER, Massey D, Blaszczyk K, Elliott T, Cotterill L, Dallal H, Lobo AJ, Mowat C, Sanderson JD, Jewell DP, Newman WG, Edwards C, Ahmad T, Mansfield JC, Satsangi J, Parkes M, Mathew CG; Donnelly P, Peltonen L, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Craddock N, Deloukas P, Duncanson A, Jankowski J, Markus HS, Mathew CG, McCarthy MI, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Samani N, Trembath RC, Viswanathan AC, Wood N, Spencer CC, Barrett JC, Bellenguez C, Davison D, Freeman C, Strange A, Donnelly P, Langford C, Hunt SE, Edkins S, Gwilliam R, Blackburn H, Bumpstead SJ, Dronov S, Gillman M, Gray E, Hammond N, Jayakumar A, McCann OT, Liddle J, Perez ML, Potter SC, Ravindrarajah R, Ricketts M, Waller M, Weston P, Widaa S, Whittaker P, Deloukas P, Peltonen L, Mathew CG, Blackwell JM, Brown MA, Corvin A, McCarthy MI, Spencer CC, Attwood AP, Stephens J, Sambrook J, Ouwehand WH, McArdle WL, Ring SM, Strachan DP. Wellcome Trust Case Control Consortium, Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41: 1330-4.
42. Wu Y, Hao X, Feng Z, Liu Y. Genetic polymorphisms in miRNAs and susceptibility to colorectal cancer. Cell Biochem Biophys 2015; 71: 271-8.
43. Zhang K, Civan J, Mukherjee S, Patel F, Yang H. Genetic variations in colorectal cancer risk and clinical outcome. World J Gastroenterol 2014; 20: 4167-77.
44. Xing J, Myers RE, He X, Qu F, Zhou F, Ma X, Hyslop T, Bao G, Wan S, Yang H, Chen Z. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer 2011; 47: 1699-707.
45. Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock S, Chen C, Hsu L, Jiao S, Conti DV, Duggan D, Fuchs CS, Gala M, Gallinger S, Haile RW, Harrison TA, Hayes R, Hazra A, Henderson B, Haiman C, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Küry S, LaCroix A, Marchand LL, Lemire M, Lindor NM, Ma J, Manson JE, Morikawa T, Nan H, Ng K, Newcomb PA, Nishihara R, Potter JD, Qu C, Schoen RE, Schumacher FR, Seminara D, Taverna D, Thibodeau S, Wactawski-Wende J, White E, Wu K, Zanke BW, Casey G, Hudson TJ, Kraft P, Peters U, Slattery ML, Ogino S, Chan AT; GECCO and CCFR. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis 2015; 36: 999-1007.
46. Shiao S, Yu C. Meta-Prediction of MTHFR Gene Polymorphism Mutations and Associated Risk for Colorectal Cancer. Biol Res Nurs 2016; 18: 357-69.
47. Yamauchi M, Lochhead P, Imamura Y, Kuchiba A, Liao X, Qian ZR, Nishihara R, Morikawa T, Shima K, Wu K, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT, Ogino S. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013; 22: 1142-52.
48. Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS. Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res 2009; 15: 5931-6.
49. Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, Liao X, Qian ZR, Ng K, Chan AT, Meyerhardt JA, Giovannucci E, Fuchs CS, Ogino S. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. Cancer Res 2013; 73: 1600-10.
50. Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT, Ogino S. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA 2013; 309: 2563-71.
51. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012; 367: 1596-606.
52. Fink SP, Yamauchi M, Nishihara R, Jung S, Kuchiba A, Wu K, Cho E, Giovannucci E, Fuchs CS, Ogino S, Markowitz SD, Chan AT. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med 2014; 6: 233re2.
53. Nan H, Morikawa T, Suuriniemi M, Imamura Y, Werner L, Kuchiba A, Yamauchi M, Hunter DJ, Kraft P, Giovannucci EL, Fuchs CS, Ogino S, Freedman ML, Chan AT. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst 2013; 105: 1852-61.
54. Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman WJ, Peters U, Hsu L, Chan AT; CCFR; GECCO. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 2015; 313: 1133-42.
55. Nishihara R, Wang M, Qian ZR, Baba Y, Yamauchi M, Mima K, Sukawa Y, Kim SA, Inamura K, Zhang X, Wu K, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Schernhammer ES. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. Am J Clin Nutr 2014; 100: 1479-88.
56. Song M, Nishihara R, Wang M, Chan AT, Qian ZR, Inamura K, Zhang X, Ng K, Kim SA, Mima K, Sukawa Y, Nosho K, Fuchs CS, Giovannucci EL, Wu K, Ogino S. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status. Gut 2016; 65: 296-304.
57. Song M, Nishihara R, Wu K, Qian ZR, Kim SA, Sukawa Y, Mima K, Inamura K, Masuda A, Yang J, Fuchs CS, Giovannucci EL, Ogino S, Chan AT. Marine ω-3 polyunsaturated fatty acids and risk for colorectal cancer according to microsatellite instability. J Natl Cancer Inst 2015; 107.
58. Cancer Screening Overview [Internet]. National Cancer Institute; 2015 [25 October 2015]. Available from: http://www.cancer.gov/about-cancer/screening/patient-screening-overview-pdq.
59. CDC-Colorectal Cancer Screening Tests [Internet]. Cdc.gov; 2014 [25 October 2015]. Available from: http://www.cdc.gov/cancer/colorectal/basic_info/screening/tests.htm.
60. Carethers JM. Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 2015; 60: 711-21.
61. Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut 2015; 64: 1158-77.
62. Holme Ø, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013: CD009-259.
63. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013; 63: 151-66.
64. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-78.
65. Holowaty EJ, Marrett LD, Parkes R, Fehringer G. Colorectal Cancer in Ontario 1971-1996 [Internet]. Cancer Care Ontario; 1998 [14 June 2016]. Available from: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13718.
66. Breitkopf CR, Asiedu GB, Egginton J, Sinicrope P, Opyrchal SM, Howell LA, Patten C, Boardman L. An investigation of the colorectal cancer experience and receptivity to family-based cancer prevention programs. Suppor Care Cancer 2014; 22: 2517-25.
67. Colon Cancer Treatment [Internet]. National Cancer Institute; 2015 [26 October 2015]. Available from: http://www.cancer.gov/types/colorectal/patient/colon-treatment-pdq.
68. Health Policy: Colorectal Cancer-SEER Landm-ark Studies [Internet]. Seer.cancer.gov; [26 October 2015]. Available from: http://seer.cancer.gov/archive/studies/endresults/study27.html.
69. Brown ML, Potosky AL. The presidential effect: the public health response to media coverage about Ronald Reagan’s colon cancer episode. Public Opin Q 1990; 54: 317-29.